A case report of acute polyradiculoneuritis developing after multiple injections of botulinum toxin for cervical dystonia

Clinical Neurology

Volumn 44, Issue 1, 2004, Pages 20-24

  Onoue, Hiroyuki ^a   Matsunobu, Aki ^a   Nagaishi, Akiko ^a   Yukitake, Motohiro ^a   Kuroda, Yasuo ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Anti ganglioside antibody; Botulinum toxin therapy; Guillain Barr syndrome; Polyradiculoneuritis

Indexed keywords

BOTULINUM TOXIN A; IMMUNOGLOBULIN G; METHYLPREDNISOLONE;

AGED; AREFLEXIA; ARTICLE; BULBAR PARALYSIS; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG MEGADOSE; DRUG PULSE THERAPY; DYSTONIA; FACIAL NERVE PARALYSIS; FLACCID PARALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; MALE; NERVE CONDUCTION; NEURITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; SENSORY DYSFUNCTION;

ACUTE DISEASE; AGED; BOTULINUM TOXIN TYPE A; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR AGENTS; POLYRADICULONEUROPATHY; TORTICOLLIS;

EID: 3042793591     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Dutch Guillain-Barré Study Group: Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann Neurol 1994; 35: 749-752
2. LeWitt PA, Trosch RM: Idiosyncratic adverse reactions to intramuscular botulinum toxin type A injection. Mov Disord 1997; 12: 1064-1067
3. Boyd RN, Britton TC, Robinson RO, et al: Transient urinary incontinence after botulinum A toxin. Lancet 1996; 348: 481-482
4. Schnider P, Brichta A, Schmied M, et al: Gallbladder dysfunction induced by botulinum A toxin. Lancet 1993; 342: 811-812
5. Ansved T, Odergren T, Borg K: Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia. Neurology 1997; 48: 1440-1442
6. Glanzman RL, Gelb DJ, Drury I, et al: Brachial plexopathy after botulinum toxin injections. Neurology 1990; 40: 1143
7. Sampaio C, Castro-Caldas A, Sales-Luis MI, et al: Brachial plexopathy after Botulinum toxin administration for cervical dystonia. J Neurol Neurosurg Psychiatry 1993; 56: 1338
8. Sheean GL, Murray NM, Marsden CD: Pain and remote weakness in limbs injected with botulinum toxin A for writer's cramp. Lancet 1995; 346: 154-156
9. Bushara KO, Park DM: Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry 1994; 57: 1437-1438
10. Girlanda P, Vita G, Nicolosi C, et al: Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. J Neurol Neurosurg Psychiatry 1992; 55: 844-845
11. Tuite PJ, Lang AE: Severe and prolonged dysphagia complicating botulinum toxin A injections for dystonia in Machado-Joseph disease. Neurology 1996; 46: 846
12. Mezaki T, Kaji R, Kohara N, et al: Development of general weakness in a patient with amyotrophic lateral sclerosis after focal botulinum toxin injection. Neurology 1996; 46: 845-846
13. Erbguth F, Claus D, Engelhardt A, et al: Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1993; 56: 1235-1236
14. Haug BA, Dressler D, Prange HW: Polyradiculoneuritis following botulinum toxin therapy. J Neurol 1990; 237: 62-63
15. Burguera JA, Villaroya T, Lopez-Alemany M: Polyradiculoneuritis after botulinum toxin therapy for cervical dystonia. Clin Neuropharmacol 2000; 23: 226-228
16. Wan X, Tang X, Cui L: Remote effects of local injection of botulinum toxin type A. Acta Acad Med Sinicae 1999; 21: 362-367
17. Willison HJ, Kennedy PG: Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol 1993; 46: 105-112
18. Bullens RW, O'Hanlon GM, Wagner E, et al: Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J Neurosci 2002; 22: 6876-6884
19. Angaut-Petit D, Molgo J, Faille L, et al: Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release. Brain Res 1998; 797: 357-360
20. Schengrund CL, DasGupta BR, Hughes CA, et al: Ganglioside-induced adherence of botulinum and tetanus neurotoxins to adducin. J Neurochem 1996; 66: 2556-2561